KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Cash from Financing Activities (2016 - 2026)

Abbott Laboratories' Cash from Financing Activities history spans 18 years, with the latest figure at $17.3 billion for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 942.48% to $17.3 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $13.1 billion, a 307.85% increase, with the full-year FY2025 number at -$6.3 billion, down 16.75% from a year prior.
  • Cash from Financing Activities hit $17.3 billion in Q1 2026 for Abbott Laboratories, up from -$1.4 billion in the prior quarter.
  • Over the last five years, Cash from Financing Activities for ABT hit a ceiling of $17.3 billion in Q1 2026 and a floor of -$3.8 billion in Q1 2022.
  • Historically, Cash from Financing Activities has averaged -$536.9 million across 5 years, with a median of -$1.5 billion in 2022.
  • Biggest five-year swings in Cash from Financing Activities: plummeted 295.35% in 2022 and later surged 942.48% in 2026.
  • Tracing ABT's Cash from Financing Activities over 5 years: stood at -$1.5 billion in 2022, then crashed by 40.84% to -$2.1 billion in 2023, then increased by 9.31% to -$1.9 billion in 2024, then grew by 24.93% to -$1.4 billion in 2025, then surged by 1339.3% to $17.3 billion in 2026.
  • Business Quant data shows Cash from Financing Activities for ABT at $17.3 billion in Q1 2026, -$1.4 billion in Q4 2025, and -$1.8 billion in Q3 2025.